Resilient Occlusal and Patients With Temporomandibular Disorder (TMD)

This study has been completed.
Sponsor:
Information provided by:
Federal University of Uberlandia
ClinicalTrials.gov Identifier:
NCT01150110
First received: June 23, 2010
Last updated: NA
Last verified: May 2007
History: No changes posted
  Purpose

The purpose of this study was to compare the effectiveness of soft occlusal splint therapy on the electromyographic activity of masticatory muscles (ateriors temporalis and masseter) before and after the application of a muscle relaxation splint. Electromyography recordings from the masseter and anterior temporalis muscles were analyzed quantitatively during maximal clench, rest and mastication usual, before and after the treatment without a splint. Ten patients whose chief complaint was Temporomandibular Disorders (TMD) were selected for the study. After the initial evaluations soft occlusal splints (muscle relaxation splints) were applied, and the patients were instructed to use the splints for four weeks. Surface electromyographic recordings were taken from each patient, as clinical evaluations of TMD (Index of Helkimo), both evaluations before the beginning of clinical therapy and after four weeks of wearing splints. The data obtained were analyzed by Wilcoxon´s and Friedman´s tests.


Condition Intervention Phase
Temporomandibular Disorders
Device: resilient occlusal splints
Phase 0

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Evaluation of Resilient Occlusal Splints in the Control of Patients With Temporomandibular Disorder (TMD)

Resource links provided by NLM:


Further study details as provided by Federal University of Uberlandia:

Study Start Date: July 2007
Study Completion Date: July 2008
Intervention Details:
    Device: resilient occlusal splints

    A resilient occlusal splints (silicone 2mm) was fabricated on the maxillary arch, using a vacuum pressing machine. The occlusal splints were adjusted to eliminate the gross interferences and to obtain occlusal stability with maximum posterior bilateral contacts.

    Patients were instructed to use the occlusal splints for 24 hours during 30 days. The use was interrupted only during meals.

  Eligibility

Ages Eligible for Study:   19 Years to 50 Years
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Patients with clinical and/or diagnosis of TMD
  • With complaints of muscle disorders and / or joint pain, pain symptoms
  • Presence of occlusal interferences
  • Minimum of 20 functional teeth in the oral cavity with subsequent bilateral occlusion

Exclusion Criteria:

  • Individuals with extensive dental flaws
  • Orthodontic treatment in progress
  • History of systemic diseases as advanced arthritis, diabetes and conservative and reversible treatments such as occlusal splints are recommended
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01150110

Locations
Brazil
Germana De Villa camargos
Uberlandia, Minas Gerais, Brazil, 39400-082
Sponsors and Collaborators
Federal University of Uberlandia
Investigators
Principal Investigator: Germana Camargos, academic Federal University of Uberlandia
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01150110     History of Changes
Other Study ID Numbers: 432
Study First Received: June 23, 2010
Last Updated: June 23, 2010
Health Authority: Brazil: Comitê de ética em pesquisa

Keywords provided by Federal University of Uberlandia:
Temporomandibular disorders
occlusal splints
electromyography
TMD (muscle and joint dysfunction)
masseteres e anterior temporalis muscles.

Additional relevant MeSH terms:
Temporomandibular Joint Disorders
Temporomandibular Joint Dysfunction Syndrome
Craniomandibular Disorders
Mandibular Diseases
Jaw Diseases
Musculoskeletal Diseases
Joint Diseases
Muscular Diseases
Stomatognathic Diseases
Myofascial Pain Syndromes
Salicylic Acid
Anti-Infective Agents
Therapeutic Uses
Pharmacologic Actions
Antifungal Agents
Keratolytic Agents
Dermatologic Agents

ClinicalTrials.gov processed this record on July 26, 2014